Viktor Kharitonin Net Worth

The trio spent $55 million for the acquisition of the plants. Throughout the 2007 IPO in London, investors estimated the company at $2.2 billion. Arbidol is only one of the well-known drugs that the company is still producing today. Meanwhile, Viktor Kharitonin is building a network of private clinics in Russia.